L. Puebla et al., HIPPOCAMPAL SOMATOSTATIN RECEPTORS AND MODULATION OF ADENYLYL-CYCLASEACTIVITY IN HISTAMINE-TREATED RATS, Molecular brain research, 35(1-2), 1996, pp. 77-83
In the present study, the effects of an intracerebroventricular (i.c.v
.) dose of histamine (0.1, 1.0 or 10.0 mu g) on the hippocampal somato
statin (SS) receptor/effector system in Wistar rats were investigated.
In view of the rapid onset of histamine action, the effects of histam
ine on the somatostatinergic system were studied 2 h after its adminis
tration. Hippocampal SS-like immunoreactivity (SSLI) levels were not m
odified by any of the histamine doses studied. SS-mediated inhibition
of basal and forskolin (FK)-stimulated adenylyl cyclase (AC) activity
was markedly increased in hippocampal membranes from rats treated with
10 mu g of histamine (23% +/- 1% vs. 17% +/- 1% and 37% +/- 2% vs. 23
% +/- 1%, respectively). In contrast, neither the basal nor the FK-sti
mulated enzyme activities were affected by histamine administration. T
he functional activity of the hippocampal guanine-nucleotide binding i
nhibitory protein (G(i) protein), as assessed by the capacity of the s
table GTP analogue 5'-guanylylimidodiphosphate (Gpp[NH]p) to inhibit F
K-stimulated AC activity, was not modified by histamine administration
. These data suggest that the increased response of the enzyme to SS w
as not related to an increased functional activity of G(i) proteins. I
n fact, the increased AC response to SS in hippocampal membranes from
histamine (10 mu g)-treated rats was associated with quantitative chan
ges in the SS receptors. Equilibrium binding data obtained with [I-125
]Tyr(11)-SS indicate an increase in the number of specific SS receptor
s (541 +/- 24 vs. 365 +/- 16 fmol/mg protein, P < 0.001) together with
a decrease in their apparent affinity (0.57 +/- 0.04 vs. 0.41 +/- 0.0
3 nM, P < 0.05) in rat hippocampal membranes from histamine (10 mu g)-
treated rats as compared to control animals. With the aim of determini
ng if these changes were related to histamine binding to its specific
receptor sites, the histaminergic H-1 and H-2 receptor antagonists mep
yramine and cimetidine, respectively, were administered 1 h before his
tamine injection. The pretreatment with mepyramine or cimetidine induc
ed an increase in the number and affinity constant of the SS receptors
whereas the simultaneous pretreatment with both histamine antagonists
prevented the histamine-induced changes in SS binding to its receptor
s. Since the hippocampal SS receptor/effector system is modulated by h
istamine, it is tempting to speculate that in the hippocampus, SS coul
d be involved as a mediator of the histamine effects on behaviors such
as learning and memory.